Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

ATOS 1.72 -0.08 (-4.44%)
price chart
Atossa Genetics Announces 2014 Financial Results and Provides Company ...
SEATTLE, WA, Mar 30, 2015 (Marketwired via COMTEX) -- Atossa Genetics, Inc. ATOS, +7.30% today announced 2014 financial results and provided an update on recent company developments.
Atossa Genetics' (ATOS) CEO Steven Quay on Q4 2014 Results - Earnings ...  Seeking Alpha (registration)
Atossa Genetics (ATOS) Stock Declines Today on Heavy Trading Volume
"We rate ATOSSA GENETICS INC (ATOS) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the ...
Know before you invest: Atossa Genetics Inc (NASDAQ:ATOS), American ...  Markets Emerging
Related articles »  
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
As a result the company improperly marketed its devices by using certain promotional claims to market the product not supported by the FDA.
Why gaining sharply? - Atossa Genetics Inc (ATOS), Penn Virginia Corporation ...  Markets Emerging
Atossa Genetics Soars On Distribution Pact With Henry Schein  Benzinga
Atossa Genetics to Present at the 27th Annual ROTH Conference March 11, 2015
SEATTLE, WA, Mar 05, 2015 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -0.99% the Breast Care Company, announced today that management will present at the 27th Annual ROTH Conference on March 11, 2015 at 12:00 pm pacific time at ...
Analyst Rating Update on Atossa Genetics Inc.  Stafford Daily
Atossa Genetics Sees Large Increase in Short Interest (ATOS)
Atossa Genetics Inc is a development-stage healthcare company focused on improving breast health through the development of a suite of laboratory developed tests (NASDAQ:ATOS), food and drug administration (FDA) cleared medical devices and ...
Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now ...
SEATTLE, WA, Dec 19, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -5.76% today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc. (the NRLBH), a CLIA-certified laboratory located in Seattle, ...
Related articles »  
Atossa Genetics launches breast cancer products in Europe (ATOS)
Nano cap Atossa Genetics (NASDAQ:ATOS) is up 17% premarket on robust volume on its announcement that the commercial launch of its ForeCYTE Breast Aspirator and Collection Kit within the European Union in underway.
Story That Gives Atossa Genetics, Inc. (NASDAQ:ATOS) A Boost � Report On ...
Atossa Genetics, Inc. (NASDAQ:ATOS)'s shares skyrocketed 48.12% and is now trading at $2.37, soon after a healthcare company that focuses on the development of a suite of laboratory services, medical devices, and therapeutics for breast cancer ...
Atossa Genetics gets bad news from FDA, shares dive
In early Wednesday pre-market trading, shares in Atossa Genetics (NASDAQ: ATOS) had fallen more than 50 percent, dropping $1.23 to $1.10.
Atossa Genetics Inc (NASDAQ:ATOS) To Focus On Commercial Launch Of ...  USMarketsDaily
7 Big Slumps: Atossa Genetics (ATOS), Baxano Surgical (BAXS), Chinanet ...  Markets Emerging
Related articles »  
Atossa Genetics Inc. Price Target Update
Atossa Genetics Inc. (NASDAQ:ATOS) stock has received a short term price target of $ 5.25 from 2 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $0.35.
Atossa Genetics Launches the ForeCYTE Breast Aspirator Within the European ...  MarketWatch
Most Volatile Stocks: Atossa Genetics, Inc. (ATOS), Bellerophon Therapeutics ...  WallStreet Scope